Paper · 11021963

c-Myc in breast cancer.

Liao DJ and 1 other. Endocr Relat Cancer, 2000. Cited by 283 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. c-Myc in breast cancer. Papers, record 11021963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11021963

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: c-Myc in breast cancer.; PubMed
Journal: Endocr Relat Cancer; PubMed
Year: 2000; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/11021963/; PubMed
DOI: https://doi.org/10.1677/erc.0.0070143; PubMed
The journal: https://conductscience.org/library/journal-index/9436481; PubMed
Citations, by iCite: 283; iCite
Relative citation ratio, by iCite: 5.12; iCite
Revised in PubMed: 2022-04-08; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Liao DJ	D J
2	Dickson RB	R B

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Breast Neoplasms	Major topic
Genes, myc	Major topic
Proto-Oncogene Proteins c-myc	Major topic
Apoptosis
Female
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by154

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 283 citations.

PMID	Title	Journal	Year	In Papers	Source
42,936,416	NDUFS1 promotes malignant breast cancer behaviors through enhancement of mitochondrial respiration and PROX1/c-Myc signaling.	iScience	2026	https://conductscience.org/library/papers/42936416	PubMed
41,625,861	Assessment of HIF-1α and c-MYC in Breast Carcinoma and Their Association With Clinicopathological Parameters: A Cross-Sectional Study.	Cureus	2025	https://conductscience.org/library/papers/41625861	PubMed
41,067,888	Loss of multilevel 3D genome organization during breast cancer progression.	Genome Res	2026	https://conductscience.org/library/papers/41067888	PubMed
40,936,780	Antisense RNAs (asRNAs) as key players in gallbladder cancer progression: a bioinformatics analysis.	Gastroenterol Hepatol Bed Bench	2025	https://conductscience.org/library/papers/40936780	PubMed
40,711,670	Targeting miR-32-5p suppresses c-MYC-driven proliferation and induces apoptosis in MCF-7 breast cancer cells.	Med Oncol	2025	https://conductscience.org/library/papers/40711670	PubMed
40,702,779	Systematic characterization of full-length RNA isoforms in human colorectal cancer at single-cell resolution.	Protein Cell	2025	https://conductscience.org/library/papers/40702779	PubMed
40,136,510	Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer.	Biology (Basel)	2025	https://conductscience.org/library/papers/40136510	PubMed
39,524,172	Sterile Alpha Motif Domain-Containing 5 Suppresses Malignant Phenotypes and Tumor Growth in Breast Cancer: Regulation of Polo-Like Kinase 1 and c-Myc Signaling in a Xenograft Model.	Cureus	2024	https://conductscience.org/library/papers/39524172	PubMed
38,584,523	20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/β‑catenin signaling pathway.	Acta Biochim Biophys Sin (Shanghai)	2024	https://conductscience.org/library/papers/38584523	PubMed
38,473,786	Characterization of MYBL1 Gene in Triple-Negative Breast Cancers and the Genes' Relationship to Alterations Identified at the Chromosome 8q Loci.	Int J Mol Sci	2024	https://conductscience.org/library/papers/38473786	PubMed

1 to 10 of 154

See all 154 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
MYC	4,609	PubTator's text mining	https://conductscience.org/library/genes/4609

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11021963

GET https://conductscience.org/api/papers/v1/11021963/cited_by?page=2

API reference For AI assistants